A CME Journal For Family Physicians

NEWS

AAAAI: New Guidelines for the Pharmacological Treatment of Seasonal Allergies

The American Academy of Allergy, Asthma, and Immunology (AAAAI) and the American College of Allergy, Asthma, and Immunology have developed new guidelines for the initial pharmacological treatment o... View More

Is Fat Cardioprotective?

The type and distribution of fat in women is associated with improved cardiometabolic risk compared to men with a similar body mass index (BMI), according to a recent study. However, ectopic fat is... View More

Diabetes Risk Raised by Frequent Mouthwash Use

Using mouth-wash at least twice a day was associated with an increased risk for developing prediabetes and diabetes among adults, according to a recent study. For their study, the researchers ... View More

Statin Use Linked to Increased Diabetes Risk

Statin use is associated with significantly higher rates of diabetes among patients already at risk, according to the results of a recent study. Previous research has indicated that the use of stat... View More

Hepatitis B Vaccine Protection Fades Over the Long-Term

Over a fourth of individuals who received the hepatitis B virus (HBV) vaccine showed signs of reduced seroprotection 18 years after vaccination, according to the results of a recent study. Although... View More

Migraine Frequency Linked to Anxiety, Depression

Patients who experience freq-uent migraines also experience more severe depression and anxiety symptoms, according to a recent study. The cross-sectio-nal study included 588 patients from an outpat... View More

Urinalysis May Lead to Inappropriate Antibiotic Treatment

Positive urinalyses are associated with inappropriate antibiotic treatment among patients with suspected urinary tract infection (UTI), according to a recent study. Findings from the study were pre... View More

Alternative to Insulin Is Effective for Type 2 Diabetes Patients With High HBA1c

Treatment with exenatide is associated with improved glycemic control among individuals with type 2 diabetes with a high hemoglobin A1c (HbA1c) level, indicating that exenatide may be a suitable al... View More

Bacterial vs Viral Infections: Novel Assay Outperforms Existing Tests

A novel assay of integrated measurements of blood-borne host-proteins better distinguishes between viral and bacterial infections than C-reactive protein (CRP), procalcitonin, and routine laborator... View More

FDA Approves Once-Weekly Diabetes Option

The FDA has approved Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation for Bydureon in a once-weekly, single-dose autoinjector device for the treatment of adults ... View More
Showing 1 to 10 of 40 entries
banner
Leave A Message